[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 479
Citations 0
Invited Commentary
Innovation in Safety: Safety in Innovation
May 2015

Challenges of Minimally Invasive Pancreas Surgery Growth With Such a High Learning Curve

Author Affiliations
  • 1Department of Surgery, University of Colorado, Aurora
JAMA Surg. 2015;150(5):423. doi:10.1001/jamasurg.2015.32

Minimally invasive pancreaticoduodenectomy (MIPD), defined as laparoscopic or robotic surgery, has been slow to develop compared with operations on other organs.1 Approximately 100 years after the first pancreaticoduodenectomy, MIPD is found to be safe, have potential oncologic advantages, and has been a large technical advance in our abilities.2,3 Despite continued skepticism, a select group of institutions, including our own, perform MIPD routinely.

First Page Preview View Large
First page PDF preview
First page PDF preview
×